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Summary.-The metastatic behaviour of the L5178E (non-M) lymphoma and a
highly metastatic subline L51787ES (M) were studied in syngeneic DBA2 mice. The
non-M tumour rarely metastasizes in intact syngeneic mice, but produces extensive
and rapidly lethal metastases when implanted into irradiated recipients. The meta-
static behaviour of the M subline is unaffected by irradiation of the host. By conven-
tional transplantation criteria, the non-M tumour is more immunogenic than the M
subline. Both tumours, however, produce similar responses in a lymphnode weight-
gain assay. Host-cell infiltration of the tumours growing s.c. is much greater in the
non-M than the M, the infiltrating cells being Fc-receptor-positive and maturing
into macrophages after 2 days in vitro.
Although spontaneous in vitro motility of the M cells is much greater than that of
the non-M, the metastatic behaviour of the tumours is clearly determined by host
immunological responses.
Two LINES of evidence suggest that an
effective host immune response to tumour-
specific transplantation-type antigens
(TSTA) is a key factor in determining the
metastatic behaviour ofexperimental sar-
comas.
(i) The incidence of distant metastases
is increased if the sarcomas are grown
in rodents immunosuppressed by whole-
bodyradiation (Eccles & Alexander, 1974),
antilymphocyte serum (Fisher & Mannick,
1970) or selectively deprived of T cells
(Eccles & Alexander, 1974, 1975).
(ii) There is an inverse correlation be-
tween the incidence of metastasis and
immunogenicity (Haywood & McKhann,
1971; Eccles & Alexander, 1974).
We now showthat both lines ofevidence
can be obtained from studies of 2 murine
lymphomas. The original tumour L5178Y/
E metastasizes only rarely when trans-
planted into its host of origin (DBA2
mice) and will be referred to as the "non-
M" line. Avariant ofthislymphomawhich
arose spontaneously during routine pas-
sage (Parr, 1972) metastasizes widely, and
will be referred to as the "M" line.
Schirrmacher et al. (1979a, b) examined
these same tumours and have shown that
the M cells (which they renamed ESb)
differ from the non-M parent line (re-
named Eb) in that they have more micro-
villi, show an increased capacity to adhere
to normal tissues, and in an in vitro assay
show increased invasiveness. They also
demonstrated differences in immunogeni-
city and in antigenic specificity, and
inferred that metastasis in this model is a
complex multifactorial event. We now
present evidence that host immunity is
the paramount factor in determining
metastatic behaviour in this model, and
that unrelated features ofthe cells, such as
adhesiveness, invasiveness and motility,
play little or no role.
MATERIALS AND METHODS
Tumours.-The origin and characteristics
of the 2 lymphomas studied have beenIMMUNITY AND LYMPHOMA METASTASIS
described in detail in an earlier publication
(Davey et al., 1976).
Migration assay.-Microhaematocrit tubes
(Hawksley) were filled with a suspension of
washed lymphoma cells at 5 x 107/ml in
Culture Medium TC 199 plus 10% foetal
bovine serum (FBS). One end of each tube
was sealed with Cristaseal (Hawksley) and
the cells centrifuged to the sealed end at
800 rev/min for 5 min. The tubes were cut
at the cell/medium interface and the cell-
containing portion attached to the base
of a sterile plastic culture chamber (P132
microchamber, Sterilin) with silicone grease.
Each culture chamber was filled with culture
medium and sealed with a coverslip attached
by greasing the well rim with silicone. The
chambers were incubated for 18 h at 37 C. The
area covered by cells migrating from the open
end of the tube was estimated by tracing
round the projected image of the migration
fan on cartridge paper, then cutting out and
weighing this area. This method compared
favourably with planimetry.
Imnmunogenicity assay.-Female DBA2
mice wereimmunizedwith 107 lymphoma cells
which had been irradiated immediately before
injection with 5000 rad of X-rays on a
220 kV X-ray machine. The cells were irra-
diated in well oxygenated culture medium
at 2 x 106/ml. In some experiments a second
immunization was given 7 days after the
first. Challenge with live lymphoma cells was
given i.p. or s.c. 7 days after the final immu-
nization.
Growth of tumour in irradiated hosts.-
Female DBA2 mice were exposed to 500 rad
of whole-body X-irradiation at a dose-rate of
100 rad/min 24 h before s.c. injection of 106
viable lymphoma cells.
Lymphnode weight-gain.-Female DBA2
mice were injected with 106 live lymphoma
cells s.c. on the left side of the thorax. This
area is drained by the anterior axillary lymph
node. At intervals of 1-2 days mice were
selected at random and killed, and the
anterior axillary lymph nodes from the
injected and contralateral sides excised and
weighed.
Infiltration of tumours by host cells.
Tumour modules were excised 7 days after
the s.c. injection of 106 lymphoma cells. The
nodules were minced finely and the fragments
suspended in culture medium containing
0-1% of trypsin and 0-1% of collagenase.
After 45 min agitation in a spinner flask at
40
room temperature, the cell-rich supernatant
was collected and the cells resuspended in
enzyme-free medium. A sample was incubated
in a haemacytometer chamber at 37°C for 5
min to allow the macrophages to adhere.
Macrophages were identified by their adher-
ence, spreading and resistance to trypsin, and
were counted under phase-contrast micro-
scopy. EA-rosette-forming cells were detected
in a mechanically prepared suspension of
similarly induced tumour nodules, using fixed
sheep erythrocytes which had been sensitized
at room temperature for 60 min with the IgG
fraction of a rabbit anti-sheep-red-cell serum
diluted to 1 in400.Afterwashing x 3, 0a1 ml of
a10%suspension ofsensitizederythrocyteswas
thoroughly mixed with 0-I ml of tumour cells
containing 2-5 x 107 cells/ml. The suspension
was centrifuged for 10 min at 800 rev/min
and the cells resuspended in 0-5 ml culture
medium. Under phase-contrast microscopy
the rosettes, defined as a nucleated cell with
3 or moreattachederythrocytes, werecounted.
The sensitized erythrocytes used in this assay
gave 950/ rosettes when mixed with mouse
peritoneal exudate cells. Furthermore, after
incubation at 37°C the rosetted red cells were
rapidly phagocytosed.
In vitro cell lines of the M and non-M cells
growing exponentially in suspension cultures
in RPMI 1640 plus 10% FBS, antibiotics,
25mM HEPES and 1O-5M 2-mercaptoethanol
contained no detectable rosetting cells. We
conclude that Fe-receptor-bearing cells ob-
tained from growing tumours are host macro-
phages.
RESULTS
Examination under the light microscope
of stained cytocentrifuge preparations of
ascitic M and non-M lymphoma cells, and
stained sections of s.c. nodules of these
tumour lines, showed them to be morpho-
logically indistinguishable; they share the
undifferentiated lymphoid morphology
typical ofanaplastic lymphomas.Electron-
microscope examination of ascitic M and
non-M cells confirmed this view. The
surface membranes of cells from both
tumour lines, although showing some
ruffling and a few microvilli, were essen-
tially regular.
A relationship between the innate
motility of tumour cells and the meta-
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No. of Migration
individual* unit
experiments areat
7 467-7+42-7
7 138-2 + 24-8
4 190-4 + 36-6
4 174-6+17-2
* Within any one experiment triplicate estimations
were performed and the result expressed as the
mean +s.d.
t Result expressed as the root mean square
(RMS) ofthe migration areas from all experiments +
RMS of s.d.
static capacity of the tumour has been
postulated (Easty & Easty, 1974). We
measured the relative motility of DBA2
lymphoid cells, using a cell-migration
assay slightly modified from an earlier
technique published by us (Currie & Sime,
1973). The results in Table I show that the
migration of M lymphoma cells was sig-
nificantly greater than that of non-M or
normal DBA2 lymphoid cells. The results
are expressed in arbitrary migration units,
equivalent to the weight in mg of the
projected image.
Growth pattern in normal DBA2 mice
Fig. 1 shows that after an i.p. inoculum
of 2-5 x 105 live tumour cells, DBA2 mice
2 4 6 8 1i0 1 2 14 16 18 0 22
.ime(days)after tumour inoculation
FIG. 1.-Mortality of DBA2 mice inoculated
i.p. with 2-5 x 105 M or non-M lymphoma
cells.
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FIG. 2. Mortality of DBA2 mice inoculated
s.c. with 106 M (0) or non-M (0) cells
compared with the growth of the tumour
nodule (- -).
died much more rapidly when injected
with M lymphoma than with non-M.
However, the growth rates of the 2 lym-
phomas in the peritoneal cavity were very
similar.
When the 2 tumours were transplanted
s.c., a similar pattern was seen (see Fig. 2).
The early death of M-inoculated mice
cannot be explained in terms of tumour
growth rate. Indeed the initial growth
rate of M tumour nodules was less than
that of the non-M. Mice with M tumours
died when the nodule was less than 1 cm
in diameter, whereas non-M-injected mice
survived until the nodule was in excess
of 2-5 cm. The experiments were prepared
with 9 or 10 mice in each group.
Postmortem examination of over 100
tumour-bearing mice revealed that macro-
scopic and microscopic metastasis from
s.c. non-M lymphoma nodules was a rare
event (< 10% of individuals affected) and
was never seen when the tumour was grow-
ing the ascitic form.
In contrast, mice bearing the M tumour
invariably showed metastatic lesions in
the liver, spleen and mesenteries, infiltra-
tion being especially marked around blood
vessels. The histological evidence, coupled
with that shown in Fig. 1 and 2, leads us
TABLE I.-Relative mobility of DBA2
lymphoid cells
DBA2 cells
Malignant: M
non-M
Normal: thymocytes
spleen cells
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FIG. 3. Mortality of whole-body irradiated
( ) and non-irradiated (- - -) DBA2
mice inoctulated s.c. with 106 non-M cells.
There were 6 mice in each group. At
necropsy, all 6 irradiated mice showed wide-
spread distant metastases. Irradiated con-
trol mice not inoculated with tumour cells
were still alive 70 days after irradiation.
to conclude that the early death of M-
tumour-bearing mice was due to the rapid
formation of distant metastases.
Growth in irradiated hosts
Evidence that the non-M line is in-
herently capable of distant dissemination,
and that it is the host which prevents the
development of overt metastases, comes
from a comparison of the growth of this
tumour in irradiated and unirradiated
syngeneic DBA2 mice (Fig. 3). In the
irradiated host, survival time was mar-
kedly less than in unirradiated controls,
and at necropsy widespread metastases
were readily seen in all irradiated but in
none ofthe unirradiated recipients. Irradia-
tion of the host did not affect survival
time or metastatic spread of the M line.
In irradiated hosts there was no significant
difference in growth pattern or lethal
capacity of the 2 tumours.
Immunogenicity
After i.p. immunization with 10 irradia-
ted (5000 rad X-rays) non-M cells, groups
of 10 DBA2 mice resisted a challenge with
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104 viable non-M cells given i.p., and 500o
of the mice resisted challenge with 105
cells. Mice were observed for 70 days,
and those surviving without evidence of
tumour were regarded as resistant. In a
similar experiment using M cells, only 20%
of the 10 immunized mice resisted chal-
lenge with 10l cells, andnonewereresistant
to 105 cells. The resistance to a challenge
following 2 i.p. immunizations with irra-
diated cells showed a similar pattern.
DBA2 mice immunized with irradiated
non-M cells showed 7000 survival after
challenge with 104 non-M cells, compared
with only 4000 survival in the comparable
group immunized and challenged with M
cells. Table II shows that the minimum
TABLE II.-Survival of normal DBA2
mice inoculated s.c. wiith M and non-M
cells
Tumouir inoctlum No. ofmice 0b survival*
M line
x 102
x 103
x 104
Non-M line
x 102
x 103
X 104
9
10
10
10
9
10
33.3
0
0
50
33-3
20
* Tumour-free at 60 days.
number of cells needed to induce a sub-
cutaneous tumour in non-immunized re-
cipients is greater for the non-M line than
the M line. This effect was not seen when
the tumour cells were injected i.p., when
10 cells from either line gave 100%
tumour takes in normal hosts.
Wfreight changes in the lymph nodes draining
tumour
The s.c. inoculation of MI and non-M
cells into the chest wall of DBA2 mice
caused a rapid weight gain in the anterior
axillary lymph node draining the area.
The enlargement of the draining node,
followed by a smaller increase in the
weight of the contralateral node, was very
similar for the 2 tumour lines (Fig. 4). Two
experiments showed however that pro-
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FIG. 4.-Weight gain of the anterior axillary
lymph node draining ( ) and contra-
lateral to (- - -) M (0) and non-M (0)
tumours growing s.c. after inoculation of 106
cells.
liferation of host lymphoid tissue is the
primary cause of the lymphnode enlarge-
ment, and that infiltration by tumour
cells makes a very minor contribution to
the weight gain.
(i) Groups of 6 DBA2 mice injected i.p.
with 2 x 106 cells from nodes draining
7-day-old tumours died from ascitic lym-
phomas in a mean of 16-2 days (for the
M line) and 19-4 days (for the non-M line).
Table III shows that this rate of tumour
TABLE III.-Mean survival time of DBA2
mice inoculated i.p. with M or non-M
lymphoma cells
I.p. inoculum
(M or
non-M cells)
2-5 x 103
2-5 x 104
2-5 x 105
106
M cells
mean
survival
time (days)
16
13
9
7
Non-M cells
mean
survival
time (days)
22
20
16
12
growth is compared to the injection of
, 103-104 lymphoma cells, i.e. that less
than 1% of the cells in the draining
lymphnode population are viable tumour
cells.
(ii) A complement-dependent cytotoxic
antibody (Davey et al., submitted for
publication) directed against a tumour-
associated antigen shared by the M and
non-M lymphomas, but absent from
normal DBA2 lymphoid cells, lysed less
than 10% ofthe cellsintheenlargedlymph
nodes draining either tumour. The results
rangedfrom 2 to 10% in 5 different experi-
ments.
These experiments were carried out
when the weight ofthe draining nodes had
increased 8-10 times, and it is clear that
most of this enlargement is caused by
normal lymphoid cells, and that infiltra-
tion by tumour cells contributes little to
the weight gain. Histopathologically these
lymph nodes showed characteristic chan-
ges oflymphoid hyperplasia, with minimal
evidence of involvement of tumour cells.
These findings suggest that the local node
responds promptly and vigorously to the
presence of both M and non-M lymphoma
cells growing s.c.
Infiltration ofthe tumour by host cells
Another indication that the non-M
lymphoma evokes a greater immune
response from the host than does the M
lymphoma is provided by the degree of
infiltration ofs.c. Mandnon-Mtumoursby
hostleucocytes. In a series ofrat sarcomas,
the macrophage content was found to
follow the immunogenicity ofthe different
tumours, and ranged from less than 5%
for non-immunogenic tumours to 50%
ofthe total cell content in highly immuno-
genic sarcomas (Eccles & Alexander, 1974).
In these sarcomas, macrophages were
identified in cell suspensions obtained
aftertrypsinization by anumberofphysio-
logical tests, the simplest being their
adherence to glass in the presence of
trypsin. The macrophage content of both
M and non-M s.c. tumours determined by
this method was less than 5% when exam-
ined on 5 separate occasions. However,
when cell suspensions in RPMI 1640 con-
taining 10% foetal calf serum plus anti-
biotics and 25mM HEPES were cultured
at 2 x 106/ml at 37°C in plastic 16mm wells
(Linbro) for 2-3 days, macrophages were
readily detectable. They were recognized
as adherent, trypsin-resistant phagocytic
cells with characteristic morphology. Sus-
594
b
D
,
, , - -
'a- -.0-IMMUNITY AND LYMPHOMA METASTASIS
pensions obtained from 5 non-M tumours
provided 16-24% macrophages (of the
original inoculum) whereas suspensions
from 5 M tumours provided 2-6% macro-
phages. Accordingly, infiltration of host
cells with Fc receptors (including macro-
phage precursors as well as other types of
leucocyte) was determined by measuring
EA rosette formation (the lymphoma cells
do not have Fc receptors on their surface
membranes). In 5 separate non-M tumours
the proportion ofFc-receptor-bearing cells
ranged from 18 to 20% whilst in 5 separate
Mtumours less than 2% ofthe cells formed
EA rosettes. After incubation at 370C, all
the rosetting cells were actively phago-
cytic.
DISCUSSION
We conclude that the lymphoma which
does not form overt metastases in normal
syngeneic host (non-M) nevertheless has
the biological properties needed for distant
dissemination, and that its failure to give
rise to overt metastases can be attributed
to the ability ofthe intact host to destroy,
in an immunologically specific manner,
tumour cells which are shed into the cir-
culation. The fact that the non-M lym-
phoma disseminates and grows readily in
irradiated hosts shows that other proper-
ties, such as the relatively low motility of
these tumour cells, do not affect their
metastatic behaviour.
The correlation between host response
and dissemination reported here for 2
murine lymphomas is similar to that found
with various rat sarcomas, in that (a)
immune suppression facilitates metastasis,
(b) the degree of infiltration of tumour
nodules by host cells is inversely related
to metastasis, and (c) immunogenicity, as
measured by graft rejection after immun-
ization, is inversely related to metastasis.
It must be stressed that immunogenicity
assessed in this way is a complex pheno-
menon. Differences in immunogenicity
may be due both to the magnitude of the
host response (e.g. the number ofcytotoxic
cells produced in the host) and to the
effectiveness ofthe immune mechanism in
destroying the tumour in vivo. The latter
includes the role of escape mechanisms
such as circulating inhibitory factors (e.g.
soluble TSTAs or their complexes with
antibodies). In an earlier investigation,
Currie & Alexander (1974) found that the
magnitude of the specific host reaction,
measured by the specific cytotoxicity of
lymphnode cells, was similar for 2 rat
sarcomas, one of which was highly immu-
nogenic and non-metastatic, and the other
almost non-immunogenic and invariably
producing distant metastases. In vitro
data suggested that the inability of the
immunized rats to reject grafts ofthe non-
immunogenic sarcoma might be due to the
inhibition of cytotoxic mononuclear cells
by antigens released from the non-
immunogenic tumour.
The lymphnode weight gains indicate
that the metastatic tumour (M) is anti-
genic and evokes a response in the lymph
node similar to that evoked by the non-M
tumour.
In conclusion, the differences in immu-
nogenicity and metastatic spread of the
M and non-M lymphomas may not be due
to the absence ofa tumour-specific antigen
from the M line, but to the ability of the
M tumour to evade the host effector
mechanisms directed against it. This may
result from the lability of tumour-specific
antigens on M tumour cells and their
appearance in the extra-cellular fluid. The
absence of host mononuclear cells from M
tumours may indicate that sensitized
lymphoid cells may interact with circulat-
ing antigen at sites distant from the
tumourandfailtorecruitmonocyteswithin
the tumour. This view is supported by our
earlier demonstration (Davey et al., 1976)
that the histocompatibility antigens in the
membrane of M cells are more labile than
those innon-Mmembranes.Theywereshed
both in vivo and in vitro at a greater rate,
and complexes formed by the addition
ofallo-antibody to intact cells disappeared
more rapidly from the surface of M cells
than from non-M.
This investigation was supported by a programme
grant from the Medical Research Council.
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